Login / Signup

Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids.

Jonathan Ian SilverbergApril W ArmstrongAndrew BlauveltKristian Reich
Published in: American journal of clinical dermatology (2023)
Keyphrases
  • atopic dermatitis
  • clinical trial
  • high intensity
  • early onset
  • randomized controlled trial
  • type diabetes
  • open label